Early transcatheter heart valve thrombosis detected by multidetector computed tomography
IJC Heart & Vessels · 2013
DOI: 10.1016/j.ijchv.2013.11.006 ↗Kurz gefasst
Fachartikel in der Zeitschrift IJC Heart & Vessels, 2013. Verfasst von Nicolaj C Hansson und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Aarhus University Hospital Skejby, Aarhus, Denmark. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 5 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 3.0). Gefördert von: Edwards Lifesciences.
Abstract (Originalsprache)
An 83-year old female with severe aortic stenosis (peak gradient 45 mm Hg; mean gradient 25 mm Hg; effective orifice area [EOA] 0.8 cm2) and reduced left ventricular function (LVEF 15 -20%) underwent transfemoral transcatheter aortic valve implantation (TAVI).The patient had a history of prior myocardial infarction, percutaneous coronary intervention (PCI), moderate renal insufficiency and abdominal aortic aneurysm, indicating high surgical risk (Society of Thoracic Surgeons score of 9.5%).The patient's treatment with aspirin (75 mg/d) and clopidogrel (75 mg/d) due to recent PCI was not discontinued prior to the procedure.A 26-mm Edwards Sapien XT transcatheter heart valve (THV) was implanted corresponding to a nominal oversizing of 15% relative to MDCT annular area.Re-dilatation of the THV was not performed.During the procedure the patient was stabilized using extracorporeal cardiopulmonary support (CPS) and inotropic therapy.The CPS circuit was heparin-coated and additionally 5000 IE of unfractionated heparin was administered during the procedure.On pre-discharge transthoracic echocardiography (TTE) the THV was well functioning (peak gradient 9 mm Hg; mean gradient 5 mm Hg; EOA 1.6 cm 2 , trivial paravalvular leakage) and the low LVEF persisted.The remaining hospitalization was uneventful, and the patient was discharged on standard post-TAVI dual antiplatelet therapy with aspirin (75 mg/d lifelong) and clopidogrel (75 mg/d for 12 months).At routine 3 months follow-up the patient's symptoms had improved from New York Heart Association functional class IV to II.Transesophageal echocardiography and TTE showed normal transvalvular gradient (peak gradient 13 mm Hg; mean gradient 8 mm Hg; EOA
Autor:innen und Institutionen
- Department of Cardiology, Aarhus University Hospital Skejby, Aarhus, Denmark.
- Department of Cardiothoracic Surgery, Aarhus University Hospital Skejby, Aarhus, Denmark.
Förderung
- Edwards Lifesciences
Zitieren
APA
Hansson, N. C., Tang, M., Jensen, J. M., Rasmussen, V. G., Poulsen, S. H., & Nørgaard, B. L. (2013). Early transcatheter heart valve thrombosis detected by multidetector computed tomography. IJC Heart & Vessels. https://doi.org/10.1016/j.ijchv.2013.11.006
Vancouver
Hansson NC, Tang M, Jensen JM, Rasmussen VG, Poulsen SH, Nørgaard BL. Early transcatheter heart valve thrombosis detected by multidetector computed tomography. IJC Heart & Vessels. 2013. doi:10.1016/j.ijchv.2013.11.006
BibTeX
@article{Hansson2013,
author = {Hansson, Nicolaj C and Tang, Mariann and Jensen, Jesper M and Rasmussen, Vibeke G and Poulsen, Steen H and Nørgaard, Bjarne L},
title = {Early transcatheter heart valve thrombosis detected by multidetector computed tomography},
journal = {IJC Heart & Vessels},
year = {2013},
doi = {10.1016/j.ijchv.2013.11.006}
}
EUVIMED